Legend Biotech Corp Adjustments For Increase Decrease In Contract Liabilities
Legend Biotech Corp (LEGN) reported Adjustments For Increase Decrease In Contract Liabilities of -$40.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities · last filed 2026-03-10
- Legend Biotech Corp adjustments for increase decrease in contract liabilities for the quarter ending 2024-12-31 was -$12.19M, a 112.19% decline year-over-year.
- Legend Biotech Corp adjustments for increase decrease in contract liabilities for the quarter ending 2023-12-31 was $100.00M.
| Period end | Adjustments For Increase Decrease In Contract Liabilities 3 month | Adjustments For Increase Decrease In Contract Liabilities 9 month | Adjustments For Increase Decrease In Contract Liabilities 12 month | Adjustments For Increase Decrease In Contract Liabilities 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$40.00M 20-F · filed 2026-03-10 | |||
| 2024-12-31 | -$12.19M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$49.70M 20-F · filed 2026-03-10 | -$49.70M 20-F · filed 2025-03-11 | |
| 2024-09-30 | -$37.51M 6-K · filed 2024-11-12 | |||
| 2023-12-31 | $100.00M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $100.00M 20-F · filed 2026-03-10 | ||
| 2023-09-30 | $0.00 6-K · filed 2024-11-12 | |||
| 2022-12-31 | $0.00 20-F · filed 2025-03-11 |